Research Studies Articles

SomnusNooze Articles > Research > Research Studies Articles


In Case You Missed It! – May 2019

In this month’s “In Case You Missed It!”, keep up to date with news we’ve shared with the sleep disorder community via social media this past month. So don’t worry if you’ve missed anything – we’ve got you covered!   CHECK OUT THE UPDATED DETAILS OF OUR...

Continue Reading

See How Our Hypersomnia Patient Registry Has Helped Researchers!

You’ve participated, and NOW THERE ARE RESULTS! Our hypersomnia-specific patient registry, which was established at CoRDS (Coordination for Rare Diseases at Sanford) in 2016 and which has grown to nearly 1,500 participants, has already helped researchers in their efforts to unlock the mysteries of rare sleep...

Continue Reading

In Case You Missed It! – November 2018

As the holidays draw near, we know that life can get more hectic. So we’re here to make your life less stressful and more thankful! In this month’s “In Case You Missed It!,” we highlight some of the most important news and social media posts...

Continue Reading

In Case You Missed It! – August 2018

This new series highlights topics relating to sleep disorders that have been in the news and/or in our recent social media posts. Check here each month to make sure that you are up-to-date on the news relating to idiopathic hypersomnia and related sleep disorders! SODIUM OXYBATE...

Continue Reading

Arise Clinical Trial

CLINICAL TRIAL ENROLLING PATIENTS WITH IDIOPATHIC HYPERSOMNIA AND NARCOLEPSY TYPE 2 Balance Therapeutics is evaluating an investigational new drug BTD-001, to treat excessive daytime sleepiness in individuals diagnosed with idiopathic hypersomnia (IH) or narcolepsy type 2 (Na-2). A Phase 2 clinical trial is currently enrolling Na-2 subjects at 26...

Continue Reading

The First Multi-Site Clinical Trial for IH and Type 2 Narcolepsy in the US Is Underway

ARISE 201 is the first double-blind, placebo-controlled, crossover, multicenter study of a drug (BTD-001) for the treatment of idiopathic hypersomnia (IH) and type 2 narcolepsy (T2N) in adults. More than 20 study sites throughout the United States are currently prescreening or screening people with IH and T2N...

Continue Reading

Get SomnusNooze, our monthly e-newsletter

Sign up to receive HF updates, news from the world of sleep research, first-person stories, and more.

You will receive an email from info@hypersomniafoundation.org (please check your junk/spam folder if needed) to confirm your subscription to our newsletter through MailChimp. You are not subscribed until you confirm. Thank you for your interest in Hypersomnia Foundation!